Loading...
XJPX
6029
Market cap11mUSD
May 23, Last price  
154.00JPY
1D
-1.28%
1Q
20.31%
Jan 2017
-78.76%
IPO
-47.50%
Name

Artra Group Corp

Chart & Performance

D1W1MN
XJPX:6029 chart
No data to show
P/E
P/S
0.37
EPS
Div Yield, %
Shrs. gr., 5y
3.11%
Rev. gr., 5y
8.36%
Revenues
4.23b
-5.85%
1,320,152,0001,490,027,0002,564,070,0003,251,564,0003,759,158,0003,479,200,0002,833,781,0002,426,748,0003,158,240,0004,671,498,0004,497,000,0004,234,000,000
Net income
-36m
L
145,542,00027,604,000268,734,000148,703,000301,430,000269,930,000-146,664,000-440,763,000-351,121,0002,104,00053,000,000-36,000,000
CFO
200m
-7.83%
306,376,00076,218,000158,177,000-178,169,000122,895,000-143,289,000-147,687,000272,183,000-208,565,000-132,554,000217,000,000200,000,000
Dividend
Dec 29, 20213.5 JPY/sh
Earnings
Aug 06, 2025

Profile

Artra Group Corporation provides support services for acupuncture and osteopathic hospitals in Japan. The company offers billing services; and HONEY-STYLE, a system, which specializes in word-of-mouth/reservation system for acupuncture and moxibustion hospital. It also operates Atlas Store, an EC site that sells consumables for acupuncture and moxibustion hospital; and a portal site providing information for judo reduction teachers, acupuncturists/kyu teachers, and anma massage shiatsu teachers through its website and e-mail magazine, as well as offers nursing care services. The company was formerly known as artra corporation and changed its name to Artra Group Corporation in 2021. Artra Group Corporation was founded in 2005 and is headquartered in Osaka, Japan.
IPO date
Dec 16, 2014
Employees
158
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,234,000
-5.85%
4,497,000
-3.74%
4,671,498
47.91%
Cost of revenue
2,899,000
4,441,189
4,635,065
Unusual Expense (Income)
NOPBT
1,335,000
55,811
36,433
NOPBT Margin
31.53%
1.24%
0.78%
Operating Taxes
15,000
19,414
24,751
Tax Rate
1.12%
34.79%
67.94%
NOPAT
1,320,000
36,397
11,682
Net income
(36,000)
-167.92%
53,000
2,419.01%
2,104
-100.60%
Dividends
(117)
(243)
Dividend yield
0.01%
0.01%
Proceeds from repurchase of equity
74,700
BB yield
-3.96%
Debt
Debt current
273,000
348,000
401,928
Long-term debt
1,005,000
1,192,216
1,509,246
Deferred revenue
223,789
Other long-term liabilities
214,000
216,848
4,441
Net debt
(811,000)
(680,784)
(100,087)
Cash flow
Cash from operating activities
200,000
217,000
(132,554)
CAPEX
(41,000)
(75,000)
(156,378)
Cash from investing activities
(31,160)
(11,000)
(154,172)
Cash from financing activities
(259,000)
(300,000)
(314,624)
FCF
1,429,294
80,872
(166,648)
Balance
Cash
1,049,000
1,140,000
1,234,142
Long term investments
1,040,000
1,081,000
777,119
Excess cash
1,877,300
1,996,150
1,777,686
Stockholders' equity
(157,527)
(128,791)
403,652
Invested Capital
3,084,527
3,328,247
3,014,181
ROIC
41.17%
1.15%
0.35%
ROCE
45.61%
1.74%
1.06%
EV
Common stock shares outstanding
10,233
9,934
9,772
Price
135.00
-28.95%
190.00
1.60%
187.00
-35.52%
Market cap
1,381,437
-26.81%
1,887,401
3.28%
1,827,414
-34.03%
EV
570,437
1,206,617
1,727,327
EBITDA
1,489,000
195,811
183,435
EV/EBITDA
0.38
6.16
9.42
Interest
13,719
14,624
16,695
Interest/NOPBT
1.03%
26.20%
45.82%